A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis

Blevins, D., Seneviratne, C., Wang, X.-Q., Johnson, B. A., & Ait-Daoud, N. (2021). A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis. Drug and Alcohol Dependence, 228, 109074. https://doi.org/10.1016/j.drugalcdep.2021.109074
Authors:
Derek Blevins
Chamindi Seneviratne
Xin-Qun Wang
Bankole A. Johnson
Nassima Ait-Daoud
Affiliated Authors:
Derek Blevins
Columbia Affiliation:
Author Keywords:
cocaine use disorder
ondansetron
pharmacogenetic
elink
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2021.109074
PMID:
34600264
DOI:
10.1016/j.drugalcdep.2021.109074
Journal:
Drug and Alcohol Dependence
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: